Greenleaf Trust Portfolio holdings
Greenleaf Trust is a privately held, trust-only bank that manages wealth and administers trusts for families. Bill Johnston started it in 1998 after national banks had swallowed up many regional and community banks, wanting a locally owned firm with fiduciary expertise that would serve families across generations. Johnston had already launched a sister firm, Greenleaf Asset Management, in 1991, and the two merged in 2002. The bank builds portfolios around what matters most to each client, whether personal, family-focused or charitable, and avoids selling its own proprietary products. It opened a separate bank, Greenleaf Trust Delaware, in 2018.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$19.4M |
| 2 |
Roper Technologies
ROP
|
+$7.36M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.23M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$4.15M |
| 5 |
Williams-Sonoma
WSM
|
+$3.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$67.4M |
| 2 |
Wells Fargo
WFC
|
+$19.1M |
| 3 |
Danaher
DHR
|
+$1.42M |
| 4 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$1.12M |
| 5 |
Aflac
AFL
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.46% |
| 2 | Miscellaneous | 5.52% |
| 3 | Technology | 2.3% |
| 4 | Financials | 2.02% |
| 5 | Consumer Staples | 1.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Stryker
SYK
$124B
| $3.08B | 81.14% |
26,491,782
-578,785
| -2% | -$67.4M |
2013 Q2
13 quarters
|
|
|
2
iShares Core S&P 500 ETF
IVV
$847B
| $71.6M | 1.88% |
329,088
+88,985
| +37% | +$19.4M |
2013 Q2
13 quarters
|
|
3
Apple
AAPL
$4.98T
| $18.9M | 0.5% |
668,848
+13,720
| +2% | +$363K |
2013 Q2
13 quarters
|
|
4
State Street Energy Select Sector SPDR ETF
XLE
$40.6B
| $18.5M | 0.49% |
524,004
-11,970
| -2% | -$410K |
2015 Q4
3 quarters
|
|
5
PepsiCo
PEP
$193B
| $17.7M | 0.47% |
162,446
-4,780
| -3% | -$515K |
2013 Q2
13 quarters
|
|
6
Chubb
CB
$139B
| $17.1M | 0.45% |
136,300
-5,937
| -4% | -$753K |
2013 Q2
13 quarters
|
|
7
Procter & Gamble
PG
$383B
| $14.7M | 0.39% |
163,672
+5,430
| +3% | +$472K |
2013 Q2
13 quarters
|
|
|
8
Aflac
AFL
$61.5B
| $14.4M | 0.38% |
400,768
-30,164
| -7% | -$1.1M |
2013 Q4
11 quarters
|
|
9
Verizon
VZ
$189B
| $14.1M | 0.37% |
271,375
+12,039
| +5% | +$646K |
2013 Q2
13 quarters
|
|
10
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $13.6M | 0.36% |
438,330
+106,275
| +32% | +$3.28M |
2013 Q2
13 quarters
|
|
|
CELG
11
DELISTED
Celgene Corp
CELG
| $13.5M | 0.35% |
128,961
+4,321
| +3% | +$468K |
2013 Q2
13 quarters
|
|
|
12
iShares Core S&P Small-Cap ETF
IJR
$103B
| $13.2M | 0.35% |
212,618
+69,194
| +48% | +$4.23M |
2013 Q2
13 quarters
|
|
13
Alphabet (Google) Class C
GOOG
$3.49T
| $13M | 0.34% |
334,820
+23,200
| +7% | +$881K |
2013 Q2
13 quarters
|
|
14
iShares S&P 500 Growth ETF
IVW
$72.1B
| $12.9M | 0.34% |
424,708
-300
| -0.1% | -$9.09K |
2013 Q2
13 quarters
|
|
15
iShares S&P 500 Value ETF
IVE
$49.9B
| $12.6M | 0.33% |
133,025
-206
| -0.2% | -$19.6K |
2013 Q2
13 quarters
|
|
16
Sherwin-Williams
SHW
$83.1B
| $12.2M | 0.32% |
132,183
+2,514
| +2% | +$244K |
2015 Q2
5 quarters
|
|
17
NextEra Energy
NEE
$182B
| $11.9M | 0.31% |
389,464
+1,116
| +0.3% | +$35.2K |
2013 Q2
13 quarters
|
|
18
Merck
MRK
$362B
| $11.9M | 0.31% |
199,457
-2,152
| -1% | -$126K |
2013 Q2
13 quarters
|
|
19
Honeywell
HON
$69.7B
| $11.7M | 0.31% |
111,916
+6,844
| +7% | +$715K |
2013 Q2
13 quarters
|
|
20
DELISTED
Ansys
ANSS
| $11.5M | 0.3% |
123,960
-4,522
| -4% | -$421K |
2016 Q1
2 quarters
|
|
21
iShares MSCI EAFE ETF
EFA
$75.6B
| $10.9M | 0.29% |
184,015
-6,990
| -4% | -$405K |
2013 Q2
13 quarters
|
|
22
Gilead Sciences
GILD
$207B
| $10.8M | 0.29% |
136,942
-6,670
| -5% | -$542K |
2015 Q2
5 quarters
|
|
23
Lockheed Martin
LMT
$131B
| $10.7M | 0.28% |
44,541
+88
| +0.2% | +$22K |
2016 Q1
2 quarters
|
|
24
US Bancorp
USB
$92.6B
| $10.3M | 0.27% |
239,344
-9,575
| -4% | -$407K |
2015 Q4
3 quarters
|
|
25
Colgate-Palmolive
CL
$76.8B
| $10.1M | 0.27% |
136,037
+2,038
| +2% | +$151K |
2013 Q2
13 quarters
|
|
Similar funds
Greenleaf Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Greenleaf Trust held 214 positions worth $3.8B, down 2.7% from $3.9B the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Greenleaf Trust's Q3 2016 filing shows 42 new, 74 increased, 56 reduced and 5 closed positions. Its largest new stake was Roper Technologies: 42,220 shares worth $7.7M. The largest sale was Stryker, an estimated $67.4M.
By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 85% a quarter earlier, followed by Miscellaneous and Technology.
- Greenleaf Trust's largest Q3 2016 buy was Roper Technologies: 42,220 shares worth $7.7M.
- Greenleaf Trust added most to iShares Core S&P 500 ETF in Q3 2016, an estimated $19.4M increase.
- Greenleaf Trust's biggest Q3 2016 reduction was Stryker, cutting an estimated $67.4M.
- Greenleaf Trust fully exited Markel Group in Q3 2016, selling an estimated $286K.
- Greenleaf Trust's ten largest holdings make up 86% of its $3.8B portfolio in Q3 2016.
- Greenleaf Trust opened 42 new positions and closed 5 in Q3 2016.
- Greenleaf Trust's portfolio value fell 2.7% quarter-over-quarter to $3.8B.
Based on Greenleaf Trust's 13F filing for Q3 2016, filed 19 Oct 2016.